For instance, a decrease in beclin-1 expression leads to accumulation of mutant huntingtin protein in Huntington’s disease (HD) and loss of laforin polyglucosan inclusions in Lafora’s body disease via activation of mTOR (mammalian/mechanistic target of rapamycin) signaling pathway [25, 26]. Here, BECN1 is linked to Huntington disease.